Stocks
CSPC Pharmaceutical Group LimitedCSPCY
OTCHealthcarePharmaceuticals$4.28-0.70%
Price as of · delayed, not real-time
A leading Chinese pharmaceutical company focused on the research, development, manufacturing, and marketing of branded generic and innovative drugs. Investors monitor CSPC for its strong position in China's growing pharmaceutical market and its pipeline of oncology and cardiovascular treatments.
Market Cap: $12.4B52W Range: $2.32 – $5.83
Congressional Interest in CSPC Pharmaceutical Group Limited (CSPCY)
1 member of Congress has disclosed 11 trades in CSPC Pharmaceutical Group Limited (CSPCY), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
11
Unique Politicians
1
Buys
6
Sells
5
Who in Congress Is Trading CSPCY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2023-07-14 | Josh Gottheimer | buy | $1K – $15K |
| 2023-06-13 | Josh Gottheimer | sell | $1K – $15K |
| 2022-12-30 | Josh Gottheimer | sell | $1K – $15K |
| 2022-04-19 | Josh Gottheimer | buy | $1K – $15K |
| 2022-03-15 | Josh Gottheimer | sell | $1K – $15K |
| 2022-01-10 | Josh Gottheimer | buy | $1K – $15K |
| 2021-12-09 | Josh Gottheimer | sell | $1K – $15K |
| 2021-09-17 | Josh Gottheimer | buy | $1K – $15K |
| 2021-04-15 | Josh Gottheimer | buy | $1K – $15K |
| 2021-04-13 | Josh Gottheimer | buy | $1K – $15K |